These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 18790261

  • 1. Anti-CD20 monoclonal antibody (rituximab) for the treatment of membranous nephropathy after living-unrelated kidney transplantation: a case report.
    Sirimongkolrat T, Premasathian N, Vongwiwatana A, Limsrichamrern S, Cheunsuchon B, Vasuvattakul S.
    Transplant Proc; 2008 Sep; 40(7):2440-1. PubMed ID: 18790261
    [Abstract] [Full Text] [Related]

  • 2. [Efficiency of rituximab treatment for recurrence of membranous glomerulopathy after renal transplantation].
    Wéclawiak H, Ribes D, Modesto A, Kamar N, Durand D, Rostaing L.
    Nephrol Ther; 2007 Apr; 3(2):65-8. PubMed ID: 17452303
    [Abstract] [Full Text] [Related]

  • 3. [Treatment of idiopathic membranous nephropathy. Is the anti-CD20 antibody rituximab a reasonable option?].
    Busch M, Gerth J, Ott U, Schip A, Haufe CC, Gröne HJ, Wolf G.
    Med Klin (Munich); 2008 Jul 15; 103(7):519-24. PubMed ID: 18604487
    [Abstract] [Full Text] [Related]

  • 4. A case of living-related renal transplant from the donor with membranous nephropathy.
    Akioka K, Okamoto M, Ushigome H, Nobori S, Suzuki T, Sakai K, Sakamoto S, Urasaki K, Yanagisawa A, Fukatsu A, Yoshimura N.
    Clin Transplant; 2009 Aug 15; 23 Suppl 20():62-6. PubMed ID: 19594600
    [Abstract] [Full Text] [Related]

  • 5. Early recurrence of nephrotic syndrome (immunoglobulin m nephropathy) after renal transplantation successfully treated with combinations of plasma exchanges, immunoglobulin, and rituximab.
    Westphal S, Hansson S, Mjörnstedt L, Mölne J, Swerkersson S, Friman S.
    Transplant Proc; 2006 Oct 15; 38(8):2659-60. PubMed ID: 17098031
    [Abstract] [Full Text] [Related]

  • 6. An attempt to extend the donor criteria for successful living-related kidney transplantation from a donor with membranous nephropathy.
    Akioka K, Okamoto M, Ushigome H, Nobori S, Suzuki T, Sakamoto S, Yoshimura N.
    Transplant Proc; 2009 Oct 15; 41(1):446-9. PubMed ID: 19249577
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Recurrent nephrotic syndrome after living-related renal transplantation resistant to plasma exchange: report of two cases.
    Masutani K, Katafuchi R, Ikeda H, Yamamoto H, Motoyama K, Sugitani A, Kanai H, Kumagai H, Hirakata H, Tanaka M, Iida M.
    Clin Transplant; 2005 Oct 15; 19 Suppl 14():59-64. PubMed ID: 15955171
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasmapheresis and rituximab.
    Hristea D, Hadaya K, Marangon N, Buhler L, Villard J, Morel P, Martin PY.
    Transpl Int; 2007 Jan 15; 20(1):102-5. PubMed ID: 17181660
    [Abstract] [Full Text] [Related]

  • 13. Membranous nephropathy: monoclonal IgG and nephrotic-range proteinuria in a renal transplant recipient.
    Short CD, Coupes BM, Brenchley PE, Martin S, Williams S, Johnson RW, Mallick NP, Williams G.
    Nephrol Dial Transplant; 1989 Jan 15; 4(12):1080-2. PubMed ID: 2517330
    [No Abstract] [Full Text] [Related]

  • 14. Membranous nephropathy: recurrence after kidney transplantation.
    Marcen R, Mampaso F, Teruel JL, Rivera ME, Orofino L, Navarro-Antolin J, Ortuño J.
    Nephrol Dial Transplant; 1996 Jun 15; 11(6):1129-33. PubMed ID: 8671981
    [Abstract] [Full Text] [Related]

  • 15. Successful living related kidney transplantation across an anti-donor HLA antibody.
    Ben-Youssef R, Iwaki Y, Baron P, Franco E, Rowsell E, Buckert L, Ojogho O.
    Transplant Proc; 2006 Jun 15; 38(5):1280-2. PubMed ID: 16797281
    [Abstract] [Full Text] [Related]

  • 16. Acute cellular rejection occurring on the first day after living-related renal transplantation: a case report.
    Maruyama M, Kenmochi T, Saigo K, Akutsu N, Iwashita C, Ohtsuki K, Kitamura H, Joh K.
    Clin Transplant; 2006 Jun 15; 20 Suppl 15():38-41. PubMed ID: 16848874
    [Abstract] [Full Text] [Related]

  • 17. Complete biopsy-proven resolution of deposits in recurrent proliferative glomerulonephritis with monoclonal IgG deposits (PGNMIGD) following rituximab treatment in renal allograft.
    Von Visger J, Cassol C, Nori U, Franco-Ahumada G, Nadasdy T, Satoskar AA.
    BMC Nephrol; 2019 Feb 14; 20(1):53. PubMed ID: 30764798
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Does MICA influence acute rejection in kidney transplantation?
    Kato M, Kinukawa T, Hattori R, Tsuji Y, Hirano A, Horie K, Tsuyuki M, Mizutani K.
    Clin Transpl; 2006 Feb 14; ():389-93. PubMed ID: 18365394
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.